Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain CORT message board posts where the ticker symbol CORT has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest CORT SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-024192 Size: 9 KB
2018-09-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-012868 Size: 8 KB
2018-08-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-023082 Size: 5 KB
2018-08-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-023081 Size: 5 KB
2018-08-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-023080 Size: 5 KB
2018-08-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-023078 Size: 5 KB
2018-08-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-023070 Size: 5 KB
2018-08-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-012759 Size: 8 KB
2018-08-20
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-012682 Size: 8 KB
2018-08-16
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001564590-18-021092 (34 Act)  Size: 4 MB
2018-08-09 000-50679
181005538
More CORT SEC Filings


Related news from
Wed, 12 Sep 2018
12:52:12 +0000
Do Options Traders Know Something About Corcept (CORT) Stock We Don't?
Investors need to pay close attention to Corcept (CORT) stock based on the movements in the options market lately.
Fri, 07 Sep 2018
12:01:31 +0000
NovoCure Stock Rose after Positive Results from Clinical Trial
On September 6, NovoCure (NVCR) stock rose 5.3% to reach $45.40 compared to the previous day’s close of $43.10. Also, on September 6, NovoCure hit its 52-week high of $46.73. Its closing price for the day represents ~182% growth from its 52-week low of $16.10 on October 13, 2017.
Tue, 04 Sep 2018
12:03:04 +0000
Why These Fundamentals Make Corcept Therapeutics Incorporated (NASDAQ:CORT) Truly A Standout Investment
Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Corcept Therapeutics Incorporated (NASDAQ:CORT) due to its excellent fundamentals in moreRead More...
Thu, 30 Aug 2018
22:04:31 +0000
8 Stocks Joel Greenblatt Continues to Buy
The stock has climbed 140% over the last 12 months and is now trading with a price-earnings ratio of 6.86 and a price-book ratio of 18.46. Jim Simons (Trades, Portfolio)' Renaissance Technologies is the largest guru shareholder of the company with 0.63% of outstanding shares, followed by Greenblatt with 0.04%. The stock has declined 4% over the last 12 months and is now trading with a price-earnings ratio of 18.40 and a price-book ratio of 4.56.
Wed, 29 Aug 2018
11:35:00 +0000
Analysis: Positioning to Benefit within ShotSpotter, Frank's International N.V., Taseko Mines, Office Depot, Rudolph Technologies, and Corcept Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Aug. 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ShotSpotter ...
Mon, 27 Aug 2018
03:55:22 +0000
Edited Transcript of CORT earnings conference call or presentation 9-Aug-18 9:00pm GMT
Q2 2018 Corcept Therapeutics Inc Earnings Call
Sat, 25 Aug 2018
22:01:51 +0000
Insider Buys Of The Week: Andeavor, Corcept, Portola
Conventional wisdom says that insiders and 10-percent owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. Portola Pharmaceuticals Inc (NASDAQ: PTLA) saw a director step up to the buy window this past week. The total of 390,000 shares of this biopharmaceutical company acquired, at per-share prices ranging from $25 to $26.95, cost the advisor more than $10.07 million.
Fri, 24 Aug 2018
11:30:00 +0000
[$$] Corcept Director Abruptly Switches to Buying Stock From Selling
Baker, a managing director of Sutter Hill Ventures and a director of Corcept (CORT) since 1999, bought a total of 321,159 shares from Aug. 14 through Aug. 20 for an average of $12.54 each, according to his Securities and Exchange Commission filings. S&P Capital IQ puts Baker’s stake at 4%, making him the fifth-largest shareholder in Corcept, which develops drugs that regulate the effects of the stress hormone cortisol. Not only does Baker’s buying represent his first open-market purchases of Corcept in more than two years, he had been selling the stock as recently as this spring.
Mon, 20 Aug 2018
20:57:00 +0000
3 High-Growth Stocks That Could Soar
Find out why two tech stocks and a small-cap biotech look like compelling investment opportunities right now.
Fri, 10 Aug 2018
16:38:00 +0000
Here's Why Corcept Therapeutics Inc. Fell as Much as 17.4% Today
The pharma company announced second-quarter 2018 earnings results and lowered full-year 2018 revenue guidance.
Fri, 10 Aug 2018
14:59:02 +0000
Corcept (CORT) Earnings and Revenues Miss Estimates in Q2
Corcept's (CORT) earnings and revenues lag estimates in Q2. Meanwhile, the company posts positive interim data from phase I/II study on its pipeline candidate relacorilant.
Fri, 10 Aug 2018
12:00:00 +0000
Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics
NEW YORK, NY / ACCESSWIRE / August 10, 2018 / U.S. markets finished mostly lower on Thursday, as broader market was dragged lower by weak performance from the industrial and energy sector matched with ...
Fri, 10 Aug 2018
11:38:33 +0000
The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 9) Acer Therapeutics Inc (NASDAQ: ACER )(HC Wainwright reiterated ...
Thu, 09 Aug 2018
22:30:10 +0000
Corcept Therapeutics (CORT) Misses Q2 Earnings and Revenue Estimates
Corcept (CORT) delivered earnings and revenue surprises of -16.67% and -9.08%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Thu, 09 Aug 2018
21:26:18 +0000
Corcept: 2Q Earnings Snapshot
The Menlo Park, California-based company said it had profit of 14 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, came to 20 cents per share. The results fell short ...
Thu, 09 Aug 2018
20:05:00 +0000
Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update
MENLO PARK, Calif., Aug. 09, 2018-- Corcept Therapeutics Incorporated, a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric ...
Thu, 09 Aug 2018
19:00:00 +0000
Corcept Therapeutics Incorporated. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Corcept Therapeutics Incorporated. (NASDAQ: CORT ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 5:00 ...
Thu, 02 Aug 2018
20:05:00 +0000
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., Aug. 02, 2018-- Corcept Therapeutics Incorporated today announced it will report second quarter financial results and provide a corporate update on August 9, 2018. The Company will ...
Fri, 27 Jul 2018
11:35:00 +0000
Initiating Free Research Reports on Celgene and Three Other Biotech Equities
Stock Research Monitor: CARA, CLDX, and CORT LONDON, UK / ACCESSWIRE / July 27, 2018 / If you want a free Stock Review on CELG sign up now at www.wallstequities.com/registration . On Thursday, benchmark ...
Fri, 29 Jun 2018
13:23:01 +0000
Options Traders Expect Huge Moves in Corcept Therapeutics (CORT) Stock
Investors in Corcept Therapeutics (CORT) need to pay close attention to the stock based on moves in the options market lately.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is a site for sharing information about the atypical investments that the majority of investors have not discovered. It is about finding the next value/growth sector/investment before all the major houses on the Street are recommending it." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards